Walgreens Boots Alliance (WBA) Financials

$11.23 -0.02 (-0.18%)

As of 04:00 PM Eastern

Annual Income Statements for Walgreens Boots Alliance

This table shows Walgreens Boots Alliance's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	8/31/2024	8/31/2023	8/31/2022	8/31/2021	8/31/2020	8/31/2019	8/31/2018	8/31/2017	8/31/2016	8/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-8,636	-3,080	4,337	2,542	456	3,982	5,024	4,078	4,173	4,220
Consolidated Net Income / (Loss)	-15,448	-3,528	4,065	2,512	424	3,962	5,031	4,101	4,191	4,279
Net Income / (Loss) Continuing Operations	-15,448	-3,528	4,065	1,955	138	3,790	5,031	4,101	4,191	4,279
Total Pre-Tax Income	-14,219	-5,419	3,985	1,995	446	4,359	5,975	4,853	5,144	5,311
Total Operating Income	-14,076	-6,882	1,387	2,342	982	4,766	6,289	5,484	6,001	4,668
Total Gross Profit	26,524	27,072	28,265	28,067	26,078	28,159	30,792	29,162	29,874	26,753
Total Revenue	147,658	139,081	132,703	132,509	121,982	120,074	131,537	118,214	117,351	103,444
Operating Revenue	147,658	139,081	132,703	132,509	121,982	120,074	131,537	118,214	117,351	103,444
Total Cost of Revenue	121,134	112,009	104,437	104,442	95,905	91,915	100,745	89,052	87,477	76,691
Operating Cost of Revenue	121,134	112,009	104,437	104,442	95,905	91,915	100,745	89,052	87,477	76,691
Total Operating Expenses	40,601	33,953	26,877	25,725	25,095	23,393	24,503	23,678	23,873	22,085
Selling, General & Admin Expense	28,113	34,205	27,295	24,586	25,436	23,557	24,694	23,813	23,910	22,400
Other Operating Expenses / (Income)	-213	-252	-418	1,139	-341	-164	-191	-135	-37	-315
Impairment Charge	12,701	0.00	0.00	-	-	-	-	-	-	-
Total Other Income / (Expense), net	-142	1,463	2,598	-347	-536	-407	-314	-631	-857	643
Interest Expense	482	580	400	905	613	650	616	693	596	605
Other Income / (Expense), net	340	2,043	2,998	558	77	243	302	62	-261	685
Income Tax Expense	1,246	-1,858	-30	667	339	577	998	760	997	1,056
Other Gains / (Losses), net	17	33	50	627	31	8.00	54	8.00	44	24
Net Income / (Loss) Attributable to Noncontrolling Interest	-6,812	-448	-271	-30	-33	-20	7.00	23	18	59
Basic Earnings per Share	($10.01)	($3.57)	$5.02	$2.94	$0.52	$8.46	$5.07	$3.80	$3.85	$4.05
Weighted Average Basic Shares Outstanding	863.10M	863.20M	864.40M	864.80M	879.40M	921.50M	991M	1.07B	1.08B	1.04B
Diluted Earnings per Share	($10.01)	($3.57)	$5.01	$2.93	$0.52	$8.44	$5.05	$3.78	$3.82	$4.00
Weighted Average Diluted Shares Outstanding	863.10M	863.20M	865.90M	866.40M	880.30M	923.50M	995M	1.08B	1.09B	1.05B
Weighted Average Basic & Diluted Shares Outstanding	864.62M	863.91M	864.81M	865.61M	865.92M	892.54M	990.90M	1.07B	1.08B	1.04B
Cash Dividends to Common per Share	$1.23	$1.92	$1.91	$1.88	$1.84	$1.78	$1.64	$1.53	$1.46	$1.37

This table shows Walgreens Boots Alliance's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-2,853	-265	-3,005	344	-5,908	-67	-180	118	703	-3,721	-415
Consolidated Net Income / (Loss)	-4,035	-605	-3,078	230	-12,322	-278	-208	-48	544	-3,816	-501
Net Income / (Loss) Continuing Operations	-4,034	-605	-3,062	230	-12,332	-278	-190	-52	537	-3,823	-497
Total Pre-Tax Income	-4,246	-538	-998	251	-13,114	-358	-374	-382	607	-5,270	-758
Total Operating Income	-5,567	-245	-977	111	-13,171	-39	-451	-477	197	-6,151	-822
Total Gross Profit	6,935	6,779	6,252	6,460	7,041	6,771	6,476	6,588	7,055	6,953	6,411
Total Revenue	38,588	39,459	37,548	36,351	37,052	36,707	35,422	35,415	34,862	33,382	32,449
Operating Revenue	38,588	39,459	37,548	36,351	37,052	36,707	35,422	35,415	34,862	33,382	32,449
Total Cost of Revenue	31,654	32,680	31,293	29,892	30,012	29,937	28,947	28,826	27,807	26,429	26,039
Operating Cost of Revenue	31,654	32,680	31,293	29,892	30,012	29,937	28,947	28,826	27,807	26,429	26,039
Total Operating Expenses	12,502	7,024	7,232	6,349	20,211	6,809	6,924	7,065	6,859	13,105	7,232
Selling, General & Admin Expense	8,891	7,015	6,948	6,393	7,921	6,851	6,990	7,123	6,934	13,158	7,320
Other Operating Expenses / (Income)	-42	9.00	-48	-44	-79	-42	-66	-58	-75	-53	-88
Impairment Charge	3,653	-	-	0.00	12,369	-	-	0.00	0.00	-	-
Total Other Income / (Expense), net	1,321	-293	-21	141	57	-319	75	95	411	882	63
Interest Expense	129	122	132	113	138	99	156	173	141	110	106
Other Income / (Expense), net	1,450	-171	111	254	195	-220	231	268	552	992	169
Income Tax Expense	-212	66	2,082	20	-782	-74	-151	-330	70	-1,447	-235
Other Adjustments to Consolidated Net Income / (Loss)	-2.00	-	-	-	10	-	-	4.00	6.00	7.00	-
Net Income / (Loss) Attributable to Noncontrolling Interest	-1,182	-340	-73	-114	-6,415	-210	-29	-166	-159	-94	-85
Basic Earnings per Share	($3.30)	($0.31)	($3.48)	$0.40	($6.85)	($0.08)	($0.21)	$0.14	$0.81	($4.31)	($0.46)
Weighted Average Basic Shares Outstanding	864.10M	863.80M	863.10M	863.10M	862.50M	863M	863.20M	863.10M	862.60M	863.60M	864.40M
Diluted Earnings per Share	($3.30)	($0.31)	($3.48)	$0.40	($6.85)	($0.08)	($0.21)	$0.14	$0.81	($4.31)	($0.47)
Weighted Average Diluted Shares Outstanding	864.10M	863.80M	863.10M	864.30M	862.50M	863M	863.20M	863.80M	863.40M	863.60M	865.90M
Weighted Average Basic & Diluted Shares Outstanding	864.74M	864.15M	864.62M	863.28M	862.71M	862.38M	863.91M	863.26M	862.80M	862.50M	864.81M

This table details how cash moves in and out of Walgreens Boots Alliance's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	8/31/2024	8/31/2023	8/31/2022	8/31/2021	8/31/2020	8/31/2019	8/31/2018	8/31/2017	8/31/2016	8/31/2015
Net Change in Cash & Equivalents	2,362	-1,703	1,289	525	-460	231	-2,522	-6,522	6,807	5,497
Net Cash From Operating Activities	1,018	2,258	3,899	5,555	5,484	5,594	8,263	7,255	7,847	6,227
Net Cash From Continuing Operating Activities	1,017	2,258	3,899	5,555	5,484	5,594	8,264	7,255	7,847	6,227
Net Income / (Loss) Continuing Operations	-15,448	-3,528	4,065	2,512	424	3,962	5,031	4,101	4,191	4,279
Consolidated Net Income / (Loss)	-15,448	-3,528	4,065	2,512	424	3,962	5,031	4,101	4,191	4,279
Depreciation Expense	2,459	2,257	1,990	1,973	1,927	2,038	1,770	1,654	1,718	1,742
Non-Cash Adjustments To Reconcile Net Income	13,575	-1,544	-2,285	409	2,235	234	-155	312	182	522
Changes in Operating Assets and Liabilities, net	431	5,073	129	661	898	-640	1,618	1,188	1,240	463
Net Cash From Investing Activities	1,878	-3,094	-1,064	4,072	-1,297	-2,307	-5,501	-843	-3,517	185
Net Cash From Continuing Investing Activities	1,878	-3,093	-1,065	4,072	-1,297	-2,307	-5,501	-843	-3,517	185
Purchase of Property, Plant & Equipment	-1,381	-2,117	-1,734	-1,379	-1,374	-1,702	-1,367	-1,351	-1,325	-1,251
Acquisitions	-402	-7,313	-2,189	-1,431	-718	-741	-4,793	-88	-126	-371
Sale of Property, Plant & Equipment	2,860	4,495	1,334	453	90	117	655	59	155	184
Other Investing Activities, net	801	1,842	1,524	902	705	19	4.00	93	5.00	-58
Net Cash From Financing Activities	-538	-887	-1,499	-9,036	-4,647	-3,047	-5,295	-12,934	2,606	-915
Net Cash From Continuing Financing Activities	-537	-886	-1,499	-9,036	-4,646	-3,046	-5,295	-12,934	2,606	-915
Repayment of Debt	-30,995	-9,329	-9,492	-19,185	-21,571	-10,461	-4,988	-6,241	-934	-10,867
Repurchase of Common Equity	-69	-1,466	-2,295	-110	-1,589	-4,160	-5,228	-5,220	-1,152	-1,226
Payment of Dividends	-1,260	-1,659	-1,659	-1,617	-1,747	-1,643	-1,739	-1,723	-1,563	-1,384
Issuance of Debt	31,363	6,275	11,947	11,817	20,206	13,044	6,486	33	6,020	12,059
Issuance of Common Equity	0.00	2,725	0.00	59	55	174	174	217	235	503
Other Financing Activities, net	424	2,568	0.00	0.00	-	-	-	-	-	-
Effect of Exchange Rate Changes	4.00	20	-47	-	-	-9.00	11	-	-129	-

This table details how cash moves in and out of Walgreens Boots Alliance's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Net Change in Cash & Equivalents	-69	-1,909	2,479	25	-132	-10	-262	-875	-2,322	1,756	-1,982
Net Cash From Operating Activities	-199	-140	1,332	604	-637	-281	1,039	-20	746	493	86
Net Cash From Continuing Operating Activities	-200	-141	1,331	605	-637	-282	1,039	-19	746	492	87
Net Income / (Loss) Continuing Operations	-4,035	-605	-3,078	230	-12,322	-278	-208	-48	544	-3,816	-501
Consolidated Net Income / (Loss)	-4,035	-605	-3,078	230	-12,322	-278	-208	-48	544	-3,816	-501
Depreciation Expense	611	625	622	607	614	616	605	597	560	495	488
Non-Cash Adjustments To Reconcile Net Income	3,933	510	526	-253	13,032	270	113	80	-800	-937	767
Changes in Operating Assets and Liabilities, net	-709	-671	3,261	21	-1,961	-890	529	-648	442	4,750	-667
Net Cash From Investing Activities	418	-76	772	204	817	85	155	334	-5,441	1,858	198
Net Cash From Continuing Investing Activities	417	-76	773	203	817	85	155	336	-5,441	1,857	198
Purchase of Property, Plant & Equipment	-219	-284	-246	-277	-352	-506	-484	-525	-498	-610	-493
Acquisitions	-7.00	-18	-196	22	-119	-109	-241	-259	-6,733	-80	-149
Sale of Property, Plant & Equipment	605	164	1,134	415	1,007	304	697	537	1,193	2,068	358
Other Investing Activities, net	38	62	81	43	281	396	183	583	597	479	482
Net Cash From Financing Activities	-288	-1,685	374	-785	-313	186	-1,460	-1,193	2,365	-599	-2,252
Net Cash From Continuing Financing Activities	-287	-1,686	375	-786	-312	186	-1,459	-1,193	2,366	-600	-2,252
Repayment of Debt	-11,398	-4,675	-7,699	-8,216	-11,345	-3,735	-3,846	-3,900	-1,509	-74	-1,844
Payment of Dividends	-216	-216	-216	-216	-413	-415	-415	-415	-414	-415	-408
Issuance of Debt	11,327	3,241	8,290	7,646	11,446	3,981	888	2,543	2,805	39	13

This table presents Walgreens Boots Alliance's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	8/31/2024	8/31/2023	8/31/2022	8/31/2021	8/31/2020	8/31/2019	8/31/2018	8/31/2017	8/31/2016	8/31/2015
Total Assets	81,037	96,628	90,124	81,285	87,174	67,598	68,124	66,009	72,688	68,782
Total Current Assets	18,335	15,503	16,902	15,814	18,073	18,700	17,846	19,753	25,883	19,657
Cash & Equivalents	1,319	728	1,358	559	469	1,023	785	3,301	9,807	3,000
Short-Term Investments	1,790	11	1,114	634	-	-	-	-	-	-
Accounts Receivable	5,851	5,381	5,017	5,663	4,110	7,226	6,573	6,528	6,260	6,849
Inventories, net	8,320	8,257	8,353	8,159	7,917	9,333	9,565	8,899	8,956	8,678
Other Current Assets	1,055	1,127	1,059	800	598	1,118	923	1,025	860	1,130
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	13,911	13,642	14,335	15,068
Total Noncurrent Assets	62,702	81,125	73,222	65,471	69,102	48,898	36,367	46,256	46,805	49,125
Long-Term Investments	2,269	3,497	5,495	6,987	7,204	6,851	6,610	6,320	6,174	1,242
Goodwill	15,506	28,187	22,280	12,421	12,013	16,560	16,914	15,632	15,527	16,372
Intangible Assets	12,973	13,635	10,730	9,936	10,072	10,876	11,783	10,156	10,302	12,351
Other Noncurrent Operating Assets	31,953	35,804	34,718	36,127	34,830	14,611	1,060	506	467	4,092
Total Liabilities & Shareholders' Equity	81,037	96,628	90,124	81,285	87,174	67,598	68,124	66,009	72,688	68,782
Total Liabilities	68,858	68,140	59,717	57,145	66,038	43,447	41,435	37,735	42,407	37,482
Total Current Liabilities	26,953	24,535	22,583	22,054	27,070	25,769	21,667	18,547	17,013	16,557
Short-Term Debt	1,505	917	1,059	1,305	3,265	5,738	1,966	251	323	1,068
Accounts Payable	14,082	12,635	11,255	11,136	10,145	14,341	13,566	12,494	11,000	10,088
Accrued Expenses	8,673	8,426	7,899	7,260	5,861	5,474	5,862	5,473	5,484	5,225
Current Deferred & Payable Income Tax Liabilities	312	209	84	94	95	216	273	329	206	176
Other Current Liabilities	2,382	2,347	2,286	2,259	2,358	0.00	-	-	-	-
Total Noncurrent Liabilities	41,905	43,605	37,134	35,091	38,969	17,678	19,768	19,188	25,394	20,925
Long-Term Debt	8,044	8,145	10,615	7,675	12,203	11,098	12,431	12,684	18,705	13,315
Asset Retirement Reserve & Litigation Obligation	6,008	6,261	551	-	-	-	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	1,195	1,318	1,442	1,850	1,367	1,785	1,815	2,281	2,644	3,538
Other Noncurrent Operating Liabilities	26,657	27,881	24,526	25,566	24,987	4,795	5,522	4,223	4,045	4,072
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	174	167	1,042	319	0.00	-	-	-	-	-
Total Equity & Noncontrolling Interests	12,005	28,322	29,366	23,822	21,136	24,152	26,689	28,274	30,281	31,300
Total Preferred & Common Equity	10,445	20,020	25,275	23,419	20,637	23,512	26,007	27,466	29,880	30,861
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	10,446	20,021	25,275	23,419	20,637	23,512	26,007	27,466	29,880	30,861
Common Stock	10,657	10,673	10,962	11,000	10,773	10,651	10,505	10,351	10,123	9,965
Retained Earnings	23,348	33,058	37,801	35,121	34,210	35,815	33,551	30,137	27,684	25,089
Treasury Stock	-20,662	-20,717	-20,683	-20,593	-20,575	-19,057	-15,047	-9,971	-4,934	-3,977
Accumulated Other Comprehensive Income / (Loss)	-2,897	-2,993	-2,805	-2,109	-3,771	-3,897	-3,002	-3,051	-2,992	-214
Noncontrolling Interest	1,561	8,302	4,091	402	498	641	682	808	401	439

This table presents Walgreens Boots Alliance's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Total Assets	70,216	78,536	81,037	82,985	84,207	97,823	96,628	98,605	100,479	92,875	90,124
Total Current Assets	16,237	17,478	18,335	16,337	16,561	17,345	15,503	16,542	17,689	19,523	16,902
Cash & Equivalents	702	859	1,319	703	668	784	728	871	1,088	2,349	1,358
Short-Term Investments	430	332	1,790	-	-	-	11	99	752	1,883	1,114
Accounts Receivable	5,940	6,191	5,851	5,949	6,200	5,972	5,381	5,843	5,730	4,853	5,017
Inventories, net	7,845	9,119	8,320	8,578	8,557	9,454	8,257	8,164	8,757	9,322	8,353
Other Current Assets	1,319	977	1,055	1,107	1,136	1,134	1,127	1,565	1,362	1,115	1,059
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	53,979	61,058	62,702	66,648	67,646	80,478	81,125	82,063	82,790	73,352	73,222
Long-Term Investments	1,380	2,172	2,269	2,961	3,256	3,400	3,497	3,527	4,069	4,426	5,495
Goodwill	11,803	15,453	15,506	15,821	15,814	28,184	28,187	28,371	28,343	22,582	22,280
Intangible Assets	10,717	12,557	12,973	12,836	12,984	13,278	13,635	13,578	13,864	10,612	10,730
Other Noncurrent Operating Assets	30,080	30,876	31,953	35,031	35,591	35,616	35,804	36,586	36,513	35,732	34,718
Total Liabilities & Shareholders' Equity	70,216	78,536	81,037	82,985	84,207	97,823	96,628	98,605	100,479	92,875	90,124
Total Liabilities	62,960	67,266	68,858	67,555	68,843	70,066	68,140	69,086	70,882	68,137	59,717
Total Current Liabilities	26,585	27,453	26,953	25,034	24,915	26,116	24,535	26,170	28,228	28,036	22,583
Short-Term Debt	1,406	446	1,505	1,506	1,937	1,670	917	3,061	4,222	3,938	1,059
Accounts Payable	13,354	14,551	14,082	13,100	12,775	13,593	12,635	12,029	12,720	12,184	11,255
Accrued Expenses	9,245	9,675	8,673	7,753	7,522	8,226	8,426	8,578	8,822	9,534	7,899
Current Deferred & Payable Income Tax Liabilities	185	392	312	292	342	276	209	146	124	109	84
Other Current Liabilities	2,394	2,389	2,382	2,384	2,339	2,350	2,347	2,356	2,340	2,271	2,286
Total Noncurrent Liabilities	36,375	39,813	41,905	42,521	43,928	43,951	43,605	42,915	42,654	40,101	37,134
Long-Term Debt	6,609	7,611	8,044	7,407	7,535	7,585	8,145	8,841	8,820	7,789	10,615
Asset Retirement Reserve & Litigation Obligation	5,757	5,982	6,008	5,890	6,123	6,366	6,261	6,407	6,365	6,427	551
Noncurrent Deferred & Payable Income Tax Liabilities	1,114	1,119	1,195	1,221	1,238	1,279	1,318	1,657	2,081	1,319	1,442
Other Noncurrent Operating Liabilities	22,895	25,101	26,657	28,003	29,032	28,721	27,881	26,010	25,388	24,566	24,526
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	104	106	174	173	172	169	167	160	158	157	1,042
Total Equity & Noncontrolling Interests	7,153	11,165	12,005	15,257	15,192	27,588	28,322	29,359	29,439	24,582	29,366
Total Preferred & Common Equity	7,110	9,939	10,445	13,642	13,484	19,481	20,020	21,063	21,192	20,576	25,275
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	7,110	9,940	10,446	13,642	13,485	19,482	20,021	21,063	21,192	20,576	25,275
Common Stock	10,581	10,594	10,657	10,651	10,639	10,629	10,673	10,679	10,641	10,489	10,962
Retained Earnings	20,007	22,861	23,348	26,571	26,448	32,573	33,058	33,654	33,952	33,664	37,801
Treasury Stock	-20,498	-20,544	-20,662	-20,686	-20,705	-20,725	-20,717	-20,731	-20,747	-20,762	-20,683
Accumulated Other Comprehensive Income / (Loss)	-2,980	-2,971	-2,897	-2,894	-2,897	-2,995	-2,993	-2,539	-2,654	-2,815	-2,805
Noncontrolling Interest	42	1,226	1,561	1,615	1,708	8,107	8,302	8,296	8,247	4,006	4,091

This table displays calculated financial ratios and metrics derived from Walgreens Boots Alliance's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	8/31/2024	8/31/2023	8/31/2022	8/31/2021	8/31/2020	8/31/2019	8/31/2018	8/31/2017	8/31/2016	8/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.17%	4.81%	0.15%	8.63%	1.59%	-8.71%	11.27%	0.74%	13.44%	35.41%
EBITDA Growth	-336.75%	-140.50%	30.82%	63.19%	-57.63%	-15.72%	16.13%	-9.71%	26.25%	25.59%
EBIT Growth	-183.86%	-210.35%	51.21%	173.84%	-78.86%	-24.00%	18.84%	-3.38%	7.23%	44.17%
NOPAT Growth	-104.53%	-444.73%	-10.36%	561.73%	-94.30%	-21.06%	13.26%	-4.40%	29.36%	56.17%
Net Income Growth	-337.87%	-186.79%	61.82%	492.45%	-89.30%	-21.25%	22.68%	-2.15%	-2.06%	110.68%
EPS Growth	-180.39%	-171.26%	70.99%	463.46%	-93.84%	67.13%	33.60%	-1.05%	-4.50%	100.00%
Operating Cash Flow Growth	-54.92%	-42.09%	-29.81%	1.29%	-1.97%	-32.30%	13.89%	-7.54%	26.02%	61.82%
Free Cash Flow Firm Growth	277.02%	48.33%	-678.11%	-84.40%	82.93%	50.31%	-50.74%	-50.85%	157.37%	-77.34%
Invested Capital Growth	-50.92%	-2.35%	36.78%	0.87%	-25.33%	-1.72%	6.66%	-5.22%	-19.58%	173.99%
Revenue Q/Q Growth	1.46%	2.18%	-1.35%	6.70%	7.76%	-11.94%	2.57%	1.30%	0.10%	0.00%
EBITDA Q/Q Growth	-5.91%	17.56%	-20.85%	10.72%	-4.66%	-13.52%	9.93%	-4.20%	19.80%	0.00%
EBIT Q/Q Growth	-4.94%	8.21%	-27.33%	17.60%	-8.63%	-18.78%	11.79%	-4.79%	16.98%	0.00%
NOPAT Q/Q Growth	-3.88%	5.12%	-47.92%	-1.48%	-71.00%	-13.68%	8.18%	-1.00%	0.75%	0.00%
Net Income Q/Q Growth	-22.82%	7.67%	-21.51%	11.40%	-43.84%	-17.27%	16.35%	-5.27%	31.46%	0.00%
EPS Q/Q Growth	-48.52%	6.79%	-19.19%	-37.79%	-82.13%	66.14%	17.99%	-4.79%	33.10%	0.00%
Operating Cash Flow Q/Q Growth	40.41%	73.03%	-22.91%	-13.15%	-5.07%	-7.26%	10.70%	-16.63%	36.61%	11.64%
Free Cash Flow Firm Q/Q Growth	5.20%	47.29%	-26.99%	-77.66%	52.07%	-11.81%	103.95%	-54.86%	0.00%	0.00%
Invested Capital Q/Q Growth	-20.94%	-9.78%	-0.77%	-2.47%	-17.61%	-5.04%	-4.89%	-1.65%	-19.78%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	17.96%	19.46%	21.30%	21.18%	21.38%	23.45%	23.41%	24.67%	25.46%	25.86%
EBITDA Margin	-7.64%	-1.86%	4.80%	3.68%	2.45%	5.87%	6.36%	6.09%	6.80%	6.11%
Operating Margin	-9.53%	-4.95%	1.05%	1.77%	0.81%	3.97%	4.78%	4.64%	5.11%	4.51%
EBIT Margin	-9.30%	-3.48%	3.30%	2.19%	0.87%	4.17%	5.01%	4.69%	4.89%	5.17%
Profit (Net Income) Margin	-10.46%	-2.54%	3.06%	1.90%	0.35%	3.30%	3.82%	3.47%	3.57%	4.14%
Tax Burden Percent	108.64%	65.10%	102.01%	125.91%	95.07%	90.89%	84.20%	84.50%	81.47%	80.57%
Interest Burden Percent	103.52%	111.99%	90.88%	68.79%	42.12%	87.02%	90.65%	87.50%	89.62%	99.22%
Effective Tax Rate	0.00%	0.00%	-0.75%	33.43%	76.01%	13.24%	16.70%	15.66%	19.38%	19.88%
Return on Invested Capital (ROIC)	-39.68%	-14.29%	4.73%	6.28%	0.81%	12.38%	16.05%	14.25%	12.94%	13.22%
ROIC Less NNEP Spread (ROIC-NNEP)	-164.08%	15.94%	123.13%	49.69%	3.82%	10.21%	12.03%	-2.23%	3.13%	36.42%
Return on Net Nonoperating Assets (RNNOA)	-36.29%	2.31%	10.17%	4.82%	1.06%	3.21%	2.26%	-0.24%	0.67%	3.26%
Return on Equity (ROE)	-75.97%	-11.98%	14.90%	11.10%	1.87%	15.59%	18.31%	14.01%	13.61%	16.48%
Cash Return on Invested Capital (CROIC)	28.64%	-11.92%	-26.33%	5.42%	29.81%	14.11%	9.61%	19.61%	34.64%	-79.82%
Operating Return on Assets (OROA)	-15.46%	-5.18%	5.12%	3.44%	1.37%	7.38%	9.83%	8.00%	8.11%	10.10%
Return on Assets (ROA)	-17.39%	-3.78%	4.74%	2.98%	0.55%	5.84%	7.50%	5.91%	5.92%	8.07%
Return on Common Equity (ROCE)	-56.91%	-9.21%	13.30%	10.80%	1.83%	15.18%	17.81%	13.72%	13.43%	16.27%
Return on Equity Simple (ROE_SIMPLE)	-147.90%	-17.62%	16.08%	10.73%	2.05%	16.85%	19.34%	14.93%	14.03%	13.87%
Net Operating Profit after Tax (NOPAT)	-9,853	-4,817	1,397	1,559	236	4,135	5,239	4,625	4,838	3,740
NOPAT Margin	-6.67%	-3.46%	1.05%	1.18%	0.19%	3.44%	3.98%	3.91%	4.12%	3.62%
Net Nonoperating Expense Percent (NNEP)	124.40%	-30.23%	-118.40%	-43.41%	-3.00%	2.17%	4.02%	16.48%	9.81%	-23.19%
Cost of Revenue to Revenue	82.04%	80.54%	78.70%	78.82%	78.62%	76.55%	76.59%	75.33%	74.54%	74.14%
SG&A Expenses to Revenue	19.04%	24.59%	20.57%	18.55%	20.85%	19.62%	18.77%	20.14%	20.37%	21.65%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	27.50%	24.41%	20.25%	19.41%	20.57%	19.48%	18.63%	20.03%	20.34%	21.35%
Earnings before Interest and Taxes (EBIT)	-13,736	-4,839	4,385	2,900	1,059	5,009	6,591	5,546	5,740	5,353
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-11,277	-2,582	6,375	4,873	2,986	7,047	8,361	7,200	7,974	6,316
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.76	1.01	1.05	1.66	1.36	1.61	2.08	2.46	2.22	2.29
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	36.50	0.00	0.00	0.00	40.24	16.39	33.00
Price to Revenue (P/Rev)	0.05	0.15	0.20	0.29	0.23	0.31	0.41	0.57	0.57	0.68
Price to Earnings (P/E)	0.00	0.00	6.14	15.25	61.33	9.48	10.74	16.56	15.91	16.72
Dividend Yield	13.30%	8.15%	6.21%	4.19%	5.70%	4.25%	3.02%	2.42%	2.37%	1.60%
Earnings Yield	0.00%	0.00%	16.30%	6.56%	1.63%	10.55%	9.31%	6.04%	6.28%	5.98%
Enterprise Value to Invested Capital (EV/IC)	0.85	1.01	1.04	1.62	1.47	1.43	1.83	2.27	2.10	1.96
Enterprise Value to Revenue (EV/Rev)	0.09	0.24	0.27	0.30	0.30	0.39	0.47	0.61	0.60	0.78
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	5.56	8.27	12.14	6.72	7.37	9.95	8.76	12.85
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	8.08	13.89	34.24	9.45	9.35	12.92	12.17	15.16
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	25.37	25.84	153.90	11.45	11.77	15.49	14.44	21.70
Enterprise Value to Operating Cash Flow (EV/OCF)	13.64	14.88	9.09	7.25	6.61	8.46	7.46	9.88	8.90	13.03
Enterprise Value to Free Cash Flow (EV/FCFF)	1.95	0.00	0.00	29.95	4.21	10.05	19.66	11.26	5.39	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.78	0.32	0.38	0.37	0.73	0.70	0.54	0.46	0.63	0.46
Long-Term Debt to Equity	0.66	0.29	0.35	0.32	0.58	0.46	0.47	0.45	0.62	0.43
Financial Leverage	0.22	0.14	0.08	0.10	0.28	0.31	0.19	0.11	0.21	0.09
Leverage Ratio	4.37	3.17	3.14	3.72	3.42	2.67	2.44	2.37	2.30	2.04
Compound Leverage Factor	4.52	3.55	2.86	2.56	1.44	2.32	2.21	2.07	2.06	2.03
Debt to Total Capital	43.95%	24.13%	27.74%	27.11%	42.26%	41.08%	35.04%	31.39%	38.59%	31.48%
Short-Term Debt to Total Capital	6.93%	2.44%	2.52%	3.94%	8.92%	14.00%	4.79%	0.61%	0.66%	2.34%
Long-Term Debt to Total Capital	37.02%	21.69%	25.22%	23.17%	33.34%	27.08%	30.26%	30.78%	37.93%	29.15%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.99%	22.55%	12.20%	2.18%	1.36%	1.56%	1.66%	1.96%	0.81%	0.96%
Common Equity to Total Capital	48.08%	53.32%	60.06%	70.71%	56.38%	57.36%	63.30%	66.65%	60.60%	67.55%
Debt to EBITDA	-0.85	-3.51	1.83	1.84	5.18	2.39	1.72	1.80	2.39	2.28
Net Debt to EBITDA	-0.37	-1.87	0.58	0.16	2.61	1.27	0.84	0.46	0.38	1.61
Long-Term Debt to EBITDA	-0.71	-3.15	1.67	1.58	4.09	1.57	1.49	1.76	2.35	2.11
Debt to NOPAT	-0.97	-1.88	8.35	5.76	65.66	4.07	2.75	2.80	3.93	3.85
Net Debt to NOPAT	-0.42	-1.00	2.65	0.51	33.09	2.17	1.34	0.72	0.63	2.71
Long-Term Debt to NOPAT	-0.82	-1.69	7.60	4.92	51.80	2.68	2.37	2.74	3.87	3.56
Altman Z-Score	1.61	1.82	2.41	2.67	2.12	3.16	3.65	3.80	3.49	3.46
Noncontrolling Interest Sharing Ratio	25.08%	23.09%	10.73%	2.70%	2.52%	2.60%	2.71%	2.06%	1.36%	1.31%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.68	0.63	0.75	0.72	0.67	0.73	0.82	1.07	1.52	1.19
Quick Ratio	0.33	0.25	0.33	0.31	0.17	0.32	0.34	0.53	0.94	0.59
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	7,112	-4,017	-7,776	1,345	8,622	4,713	3,136	6,365	12,951	-22,576
Operating Cash Flow to CapEx	0.00%	0.00%	974.75%	599.89%	427.10%	352.93%	1,160.53%	561.53%	670.68%	583.60%
Free Cash Flow to Firm to Interest Expense	14.75	-6.93	-19.44	1.49	14.06	7.25	5.09	9.19	21.73	-37.32
Operating Cash Flow to Interest Expense	2.11	3.89	9.75	6.14	8.95	8.61	13.41	10.47	13.17	10.29
Operating Cash Flow Less CapEx to Interest Expense	5.18	7.99	8.75	5.11	6.85	6.17	12.26	8.60	11.20	8.53
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.66	1.49	1.55	1.57	1.58	1.77	1.96	1.70	1.66	1.95
Accounts Receivable Turnover	26.29	26.75	24.85	27.12	21.52	17.40	20.08	18.49	17.90	20.55
Inventory Turnover	14.61	13.49	12.65	12.99	11.12	9.73	10.91	9.98	9.92	10.40
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	9.55	8.45	7.98	7.57
Accounts Payable Turnover	9.07	9.38	9.33	9.82	7.83	6.59	7.73	7.58	8.30	10.65
Days Sales Outstanding (DSO)	13.88	13.64	14.69	13.46	16.96	20.97	18.18	19.74	20.39	17.76
Days Inventory Outstanding (DIO)	24.97	27.06	28.85	28.09	32.83	37.52	33.45	36.59	36.79	35.11
Days Payable Outstanding (DPO)	40.25	38.92	39.13	37.19	46.60	55.41	47.21	48.15	44.00	34.27
Cash Conversion Cycle (CCC)	-1.39	1.78	4.41	4.36	3.19	3.09	4.42	8.19	13.18	18.60
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	16,349	33,314	34,114	24,941	24,727	33,113	33,691	31,588	33,328	41,441
Invested Capital Turnover	5.95	4.13	4.49	5.34	4.22	3.59	4.03	3.64	3.14	3.66
Increase / (Decrease) in Invested Capital	-16,965	-800	9,173	214	-8,386	-578	2,103	-1,740	-8,113	26,316
Enterprise Value (EV)	13,884	33,607	35,451	40,289	36,258	47,353	61,652	71,652	69,849	81,144
Market Capitalization	7,978	20,312	26,611	38,768	27,965	37,750	53,968	67,530	66,401	70,564
Book Value per Share	$12.10	$23.19	$29.24	$27.07	$23.82	$26.03	$26.21	$25.67	$27.61	$28.25
Tangible Book Value per Share	($20.89)	($25.25)	($8.95)	$1.23	($1.67)	($4.34)	($2.71)	$1.57	$3.74	$1.96
Total Capital	21,728	37,551	42,082	33,121	36,604	40,988	41,086	41,209	49,309	45,683
Total Debt	9,549	9,062	11,674	8,980	15,468	16,836	14,397	12,935	19,028	14,383
Total Long-Term Debt	8,044	8,145	10,615	7,675	12,203	11,098	12,431	12,684	18,705	13,315
Net Debt	4,171	4,826	3,707	800	7,795	8,962	7,002	3,314	3,047	10,141
Capital Expenditures (CapEx)	-1,479	-2,378	400	926	1,284	1,585	712	1,292	1,170	1,067
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-10,222	-8,854	-7,094	-6,128	-6,201	-2,354	-2,640	-1,844	-614	1,168
Debt-free Net Working Capital (DFNWC)	-7,113	-8,115	-4,622	-4,935	-5,732	-1,331	-1,855	1,457	9,193	4,168
Net Working Capital (NWC)	-8,618	-9,032	-5,681	-6,240	-8,997	-7,069	-3,821	1,206	8,870	3,100
Net Nonoperating Expense (NNE)	5,595	-1,289	-2,668	-953	-188	173	208	524	647	-539
Net Nonoperating Obligations (NNO)	4,170	4,825	3,706	800	3,591	8,961	7,002	3,314	3,047	10,141
Total Depreciation and Amortization (D&A)	2,459	2,257	1,990	1,973	1,927	2,038	1,770	1,654	2,234	963
Debt-free, Cash-free Net Working Capital to Revenue	-6.92%	-6.37%	-5.35%	-4.62%	-5.08%	-1.96%	-2.01%	-1.56%	-0.52%	1.13%
Debt-free Net Working Capital to Revenue	-4.82%	-5.83%	-3.48%	-3.72%	-4.70%	-1.11%	-1.41%	1.23%	7.83%	4.03%
Net Working Capital to Revenue	-5.84%	-6.49%	-4.28%	-4.71%	-7.38%	-5.89%	-2.90%	1.02%	7.56%	3.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($10.01)	($3.57)	$5.02	$2.94	$0.52	$4.32	$5.07	$3.80	$3.85	$4.05
Adjusted Weighted Average Basic Shares Outstanding	863.10M	863.20M	864.40M	864.80M	879.40M	921.50M	991M	1.07B	1.08B	1.09B
Adjusted Diluted Earnings per Share	($10.01)	($3.57)	$5.01	$2.93	$0.52	$4.31	$5.05	$3.78	$3.82	$4.00
Adjusted Weighted Average Diluted Shares Outstanding	863.10M	863.20M	865.90M	866.40M	880.30M	923.50M	995M	1.08B	1.09B	1.05B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	864.62M	863.91M	864.81M	865.61M	865.92M	892.54M	949.16M	1.08B	1.08B	1.04B
Normalized Net Operating Profit after Tax (NOPAT)	-963	-4,817	971	1,559	687	4,135	5,239	4,625	4,838	3,740
Normalized NOPAT Margin	-0.65%	-3.46%	0.73%	1.18%	0.56%	3.44%	3.98%	3.91%	4.12%	3.62%
Pre Tax Income Margin	-9.63%	-3.90%	3.00%	1.51%	0.37%	3.63%	4.54%	4.11%	4.38%	5.13%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-28.50	-8.34	10.96	3.20	1.73	7.71	10.70	8.00	9.63	8.85
NOPAT to Interest Expense	-20.44	-8.31	3.49	1.72	0.38	6.36	8.50	6.67	8.12	6.18
EBIT Less CapEx to Interest Expense	-25.43	-4.24	9.96	2.18	-0.37	5.27	9.54	6.14	7.67	7.08
NOPAT Less CapEx to Interest Expense	-17.37	-4.21	2.49	0.70	-1.71	3.92	7.35	4.81	6.15	4.42
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-8.16%	-47.02%	40.81%	64.37%	412.03%	41.47%	34.57%	42.01%	37.29%	32.34%
Augmented Payout Ratio	-8.60%	-88.58%	97.27%	68.75%	786.79%	146.47%	138.48%	169.30%	64.78%	61.00%

This table displays calculated financial ratios and metrics derived from Walgreens Boots Alliance's official financial filings.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period end date	2/28/2025	11/30/2024	8/31/2024	5/31/2024	2/29/2024	11/30/2023	8/31/2023	5/31/2023	2/28/2023	11/30/2022	8/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.15%	7.50%	6.00%	2.64%	6.28%	9.96%	9.16%	8.65%	3.28%	-1.53%	-5.29%
EBITDA Growth	71.64%	-41.46%	-163.38%	150.52%	-1,044.39%	107.65%	333.33%	-31.69%	-16.73%	-206.00%	-110.90%
EBIT Growth	68.27%	-60.62%	-293.64%	274.64%	-1,832.44%	94.98%	66.31%	-332.22%	-28.53%	-232.28%	-165.56%
NOPAT Growth	57.73%	-528.21%	-116.63%	130.59%	-5,390.11%	99.37%	45.13%	-49.06%	-82.91%	-461.67%	-278.47%
Net Income Growth	67.25%	-117.63%	-1,379.81%	579.17%	-2,365.07%	92.71%	58.48%	-120.96%	-32.51%	-208.07%	-181.73%
EPS Growth	51.82%	-287.50%	-1,557.14%	185.71%	-945.68%	98.14%	55.32%	-57.58%	-20.59%	-204.36%	-165.28%
Operating Cash Flow Growth	68.76%	50.18%	28.20%	3,120.00%	-185.39%	-157.00%	1,108.14%	-101.23%	-31.24%	-55.14%	-93.09%
Free Cash Flow Firm Growth	-35.53%	430.64%	3,261.78%	667.83%	2,097.37%	-209.83%	104.97%	68.12%	103.13%	180.80%	-9,091.69%
Invested Capital Growth	-38.98%	-51.37%	-50.92%	-44.00%	-43.07%	18.06%	-2.35%	7.40%	-0.34%	-24.25%	36.78%
Revenue Q/Q Growth	-2.21%	5.09%	3.29%	-1.89%	0.94%	3.63%	0.02%	1.59%	4.43%	2.88%	-0.45%
EBITDA Q/Q Growth	-1,777.51%	185.66%	-125.10%	107.86%	-3,562.75%	-7.27%	-0.77%	-70.36%	128.07%	-2,726.67%	-129.05%
EBIT Q/Q Growth	-889.66%	51.96%	-337.26%	102.81%	-4,910.04%	-17.73%	-5.26%	-127.90%	114.52%	-690.05%	-825.56%
NOPAT Q/Q Growth	-2,172.24%	74.92%	-769.47%	101.11%	-33,671.79%	91.35%	5.45%	-291.59%	104.05%	-648.30%	-156.88%
Net Income Q/Q Growth	-566.94%	80.34%	-1,438.26%	101.87%	-4,332.37%	-33.65%	-333.33%	-108.82%	114.26%	-661.68%	-318.78%
EPS Q/Q Growth	-964.52%	91.09%	-970.00%	105.84%	-8,462.50%	61.90%	-250.00%	-82.72%	118.79%	-817.02%	-242.42%
Operating Cash Flow Q/Q Growth	-42.14%	-110.51%	120.53%	194.82%	-126.69%	-127.05%	5,295.00%	-102.68%	51.32%	473.26%	-94.72%
Free Cash Flow Firm Q/Q Growth	-74.51%	2.52%	-0.40%	147.75%	230.70%	-1,142.39%	116.82%	-1,058.73%	-93.47%	147.15%	-7.96%
Invested Capital Q/Q Growth	-20.07%	-2.35%	-20.94%	-1.11%	-36.30%	-1.46%	-9.78%	0.53%	32.09%	-18.49%	-0.77%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	17.97%	17.18%	16.65%	17.77%	19.00%	18.45%	18.28%	18.60%	20.24%	20.83%	19.76%
EBITDA Margin	-9.09%	0.53%	-0.65%	2.67%	-33.36%	0.97%	1.09%	1.10%	3.75%	-13.97%	-0.51%
Operating Margin	-14.43%	-0.62%	-2.60%	0.31%	-35.55%	-0.11%	-1.27%	-1.35%	0.57%	-18.43%	-2.53%
EBIT Margin	-10.67%	-1.05%	-2.31%	1.00%	-35.02%	-0.71%	-0.62%	-0.59%	2.15%	-15.45%	-2.01%
Profit (Net Income) Margin	-10.46%	-1.53%	-8.20%	0.63%	-33.26%	-0.76%	-0.59%	-0.14%	1.56%	-11.43%	-1.54%
Tax Burden Percent	95.03%	112.45%	308.42%	91.63%	93.96%	77.65%	55.62%	12.57%	89.62%	72.41%	66.10%
Interest Burden Percent	103.13%	129.33%	115.24%	68.77%	101.06%	138.22%	170.00%	182.78%	81.04%	102.15%	116.08%
Effective Tax Rate	0.00%	0.00%	0.00%	7.97%	0.00%	0.00%	0.00%	0.00%	11.53%	0.00%	0.00%
Return on Invested Capital (ROIC)	-91.14%	-2.68%	-10.83%	1.42%	-124.84%	-0.35%	-3.68%	-3.60%	1.81%	-52.86%	-7.97%
ROIC Less NNEP Spread (ROIC-NNEP)	-93.64%	-11.56%	-64.06%	3.44%	-173.78%	-6.51%	-1.15%	1.78%	7.82%	-37.57%	-4.67%
Return on Net Nonoperating Assets (RNNOA)	-45.74%	-2.89%	-14.17%	0.97%	-49.01%	-1.01%	-0.17%	0.31%	1.57%	-4.14%	-0.39%
Return on Equity (ROE)	-136.89%	-5.57%	-25.00%	2.39%	-173.85%	-1.36%	-3.84%	-3.29%	3.38%	-57.00%	-8.35%
Cash Return on Invested Capital (CROIC)	20.65%	28.14%	28.64%	23.47%	20.55%	-18.34%	-11.92%	-21.38%	-13.16%	14.47%	-26.33%
Operating Return on Assets (OROA)	-21.00%	-1.80%	-3.83%	1.61%	-54.84%	-1.05%	-0.93%	-0.84%	2.97%	-21.57%	-3.12%
Return on Assets (ROA)	-20.58%	-2.62%	-13.63%	1.01%	-52.07%	-1.13%	-0.87%	-0.19%	2.15%	-15.96%	-2.39%
Return on Common Equity (ROCE)	-124.63%	-4.20%	-18.73%	1.84%	-134.08%	-1.04%	-2.96%	-2.56%	2.64%	-45.95%	-7.46%
Return on Equity Simple (ROE_SIMPLE)	-105.32%	-158.72%	0.00%	-92.20%	-95.34%	0.05%	0.00%	-18.14%	-16.72%	-15.95%	0.00%
Net Operating Profit after Tax (NOPAT)	-3,897	-172	-684	102	-9,220	-27	-316	-334	174	-4,306	-575
NOPAT Margin	-10.10%	-0.43%	-1.82%	0.28%	-24.88%	-0.07%	-0.89%	-0.94%	0.50%	-12.90%	-1.77%
Net Nonoperating Expense Percent (NNEP)	2.50%	8.88%	53.23%	-2.02%	48.94%	6.16%	-2.52%	-5.38%	-6.01%	-15.28%	-3.30%
Return On Investment Capital (ROIC_SIMPLE)	-25.69%	-0.89%	-	-	-	-0.07%	-	-	-	-	-
Cost of Revenue to Revenue	82.03%	82.82%	83.34%	82.23%	81.00%	81.56%	81.72%	81.39%	79.76%	79.17%	80.25%
SG&A Expenses to Revenue	23.04%	17.78%	18.50%	17.59%	21.38%	18.66%	19.73%	20.11%	19.89%	39.42%	22.56%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	32.40%	17.80%	19.26%	17.47%	54.55%	18.55%	19.55%	19.95%	19.67%	39.26%	22.29%
Earnings before Interest and Taxes (EBIT)	-4,117	-416	-866	365	-12,976	-259	-220	-209	749	-5,159	-653
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-3,506	209	-244	972	-12,362	357	385	388	1,309	-4,664	-165
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.30	0.78	0.76	1.03	1.36	0.82	1.01	1.16	1.35	1.63	1.05
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.06	0.05	0.05	0.10	0.13	0.11	0.15	0.18	0.21	0.25	0.20
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	27.70	0.00	0.00	0.00	0.00	6.14
Dividend Yield	9.36%	11.09%	13.30%	9.00%	7.95%	10.42%	8.15%	6.76%	5.77%	4.95%	6.21%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	3.61%	0.00%	0.00%	0.00%	0.00%	16.30%
Enterprise Value to Invested Capital (EV/IC)	1.16	0.86	0.85	1.02	1.23	0.89	1.01	1.09	1.20	1.46	1.04
Enterprise Value to Revenue (EV/Rev)	0.10	0.09	0.09	0.14	0.18	0.21	0.24	0.30	0.33	0.31	0.27
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	11.99	0.00	0.00	0.00	0.00	5.56
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	479.43	0.00	0.00	0.00	0.00	8.08
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	25.37
Enterprise Value to Operating Cash Flow (EV/OCF)	9.31	11.91	13.64	29.00	255.10	19.71	14.88	30.94	14.96	12.36	9.09
Enterprise Value to Free Cash Flow (EV/FCFF)	4.27	2.01	1.95	3.11	4.35	0.00	0.00	0.00	0.00	8.72	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.10	0.71	0.78	0.58	0.62	0.33	0.32	0.40	0.44	0.47	0.38
Long-Term Debt to Equity	0.91	0.68	0.66	0.48	0.49	0.27	0.29	0.30	0.30	0.31	0.35
Financial Leverage	0.49	0.25	0.22	0.28	0.28	0.16	0.14	0.18	0.20	0.11	0.08
Leverage Ratio	6.83	4.52	4.37	4.04	4.11	3.63	3.17	3.15	3.15	3.26	3.14
Compound Leverage Factor	7.04	5.84	5.03	2.78	4.15	5.02	5.39	5.76	2.55	3.33	3.65
Debt to Total Capital	52.48%	41.69%	43.95%	36.61%	38.14%	25.01%	24.13%	28.73%	30.59%	32.16%	27.74%
Short-Term Debt to Total Capital	9.21%	2.31%	6.93%	6.19%	7.80%	4.51%	2.44%	7.39%	9.90%	10.80%	2.52%
Long-Term Debt to Total Capital	43.28%	39.38%	37.02%	30.43%	30.34%	20.49%	21.69%	21.34%	20.69%	21.36%	25.22%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.96%	6.89%	7.99%	7.35%	7.57%	22.36%	22.55%	20.41%	19.71%	11.42%	12.20%
Common Equity to Total Capital	46.56%	51.43%	48.08%	56.04%	54.30%	52.64%	53.32%	50.85%	49.70%	56.43%	60.06%
Debt to EBITDA	-3.12	-0.71	-0.85	-0.84	-0.84	3.79	-3.51	-3.80	-4.42	-4.36	1.83
Net Debt to EBITDA	-2.14	-0.41	-0.37	-0.49	-0.49	2.08	-1.87	-2.36	-2.42	-1.14	0.58
Long-Term Debt to EBITDA	-2.57	-0.67	-0.71	-0.70	-0.67	3.11	-3.15	-2.82	-2.99	-2.90	1.67
Debt to NOPAT	-1.71	-0.81	-0.97	-0.94	-0.96	-17.17	-1.88	-2.34	-2.63	-2.77	8.35
Net Debt to NOPAT	-1.18	-0.47	-0.42	-0.55	-0.56	-9.41	-1.00	-1.46	-1.44	-0.73	2.65
Long-Term Debt to NOPAT	-1.41	-0.76	-0.82	-0.78	-0.76	-14.07	-1.69	-1.74	-1.78	-1.84	7.60
Altman Z-Score	2.28	2.22	2.13	2.22	1.69	1.94	1.98	1.95	1.94	1.93	2.23
Noncontrolling Interest Sharing Ratio	8.96%	24.61%	25.08%	22.79%	22.87%	23.69%	23.09%	22.02%	21.84%	19.39%	10.73%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.61	0.64	0.68	0.65	0.66	0.66	0.63	0.63	0.63	0.70	0.75
Quick Ratio	0.27	0.27	0.33	0.27	0.28	0.26	0.25	0.26	0.27	0.32	0.33
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	4,254	16,692	16,281	16,347	6,598	-5,048	484	-2,879	300	4,596	-9,748
Operating Cash Flow to CapEx	0.00%	-116.67%	0.00%	0.00%	0.00%	-139.11%	0.00%	0.00%	0.00%	0.00%	63.70%
Free Cash Flow to Firm to Interest Expense	32.98	136.82	123.34	144.67	47.81	-50.99	3.10	-16.64	2.13	41.78	-91.97
Operating Cash Flow to Interest Expense	-1.54	-1.15	10.09	5.35	-4.62	-2.84	6.66	-0.12	5.29	4.48	0.81
Operating Cash Flow Less CapEx to Interest Expense	1.45	-2.13	16.82	6.57	0.13	-4.88	8.03	-0.05	10.22	17.74	-0.46
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.97	1.71	1.66	1.60	1.57	1.49	1.49	1.42	1.38	1.40	1.55
Accounts Receivable Turnover	25.03	24.73	26.29	24.68	24.24	26.31	26.75	25.03	24.11	24.45	24.85
Inventory Turnover	15.31	13.34	14.61	14.19	13.60	12.30	13.49	13.08	12.01	11.12	12.65
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	9.61	8.80	9.07	9.45	9.23	8.96	9.38	9.16	8.90	8.49	9.33
Days Sales Outstanding (DSO)	14.58	14.76	13.88	14.79	15.06	13.87	13.64	14.58	15.14	14.93	14.69
Days Inventory Outstanding (DIO)	23.85	27.36	24.97	25.72	26.84	29.66	27.06	27.91	30.39	32.81	28.85
Days Payable Outstanding (DPO)	37.99	41.46	40.25	38.61	39.52	40.72	38.92	39.85	41.03	43.01	39.13
Cash Conversion Cycle (CCC)	0.44	0.66	-1.39	1.90	2.37	2.81	1.78	2.64	4.51	4.74	4.41
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	12,760	15,964	16,349	20,679	20,911	32,827	33,314	36,924	36,729	27,806	34,114
Invested Capital Turnover	9.03	6.17	5.95	5.05	5.02	4.70	4.13	3.82	3.62	4.10	4.49
Increase / (Decrease) in Invested Capital	-8,151	-16,863	-16,965	-16,245	-15,818	5,021	-800	2,545	-126	-8,902	9,173
Enterprise Value (EV)	14,861	13,806	13,884	21,027	25,765	29,245	33,607	40,374	44,180	40,713	35,451
Market Capitalization	9,212	7,780	7,978	13,990	18,337	15,898	20,312	24,513	28,642	33,481	26,611
Book Value per Share	$8.23	$11.50	$12.10	$15.81	$15.64	$22.57	$23.19	$24.41	$24.57	$23.83	$29.24
Tangible Book Value per Share	($17.83)	($20.90)	($20.89)	($17.40)	($17.76)	($25.47)	($25.25)	($24.21)	($24.37)	($14.61)	($8.95)
Total Capital	15,272	19,328	21,728	24,343	24,836	37,012	37,551	41,421	42,639	36,466	42,082
Total Debt	8,015	8,057	9,549	8,913	9,472	9,255	9,062	11,902	13,042	11,727	11,674
Total Long-Term Debt	6,609	7,611	8,044	7,407	7,535	7,585	8,145	8,841	8,820	7,789	10,615
Net Debt	5,503	4,694	4,171	5,249	5,548	5,071	4,826	7,405	7,133	3,069	3,707
Capital Expenditures (CapEx)	-386	120	-888	-138	-655	202	-213	-12	-695	-1,458	135
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-10,074	-10,720	-10,222	-7,894	-7,085	-7,885	-8,854	-7,537	-8,157	-8,807	-7,094
Debt-free Net Working Capital (DFNWC)	-8,942	-9,529	-7,113	-7,191	-6,417	-7,101	-8,115	-6,567	-6,317	-4,575	-4,622
Net Working Capital (NWC)	-10,348	-9,975	-8,618	-8,697	-8,354	-8,771	-9,032	-9,628	-10,539	-8,513	-5,681
Net Nonoperating Expense (NNE)	138	434	2,394	-128	3,102	251	-108	-286	-370	-490	-74
Net Nonoperating Obligations (NNO)	5,503	4,693	4,170	5,249	5,547	5,070	4,825	7,405	7,132	3,067	3,706
Total Depreciation and Amortization (D&A)	611	625	622	607	614	616	605	597	560	495	488
Debt-free, Cash-free Net Working Capital to Revenue	-6.63%	-7.13%	-6.92%	-5.42%	-4.90%	-5.54%	-6.37%	-5.54%	-6.12%	-6.66%	-5.35%
Debt-free Net Working Capital to Revenue	-5.89%	-6.34%	-4.82%	-4.94%	-4.44%	-4.99%	-5.83%	-4.82%	-4.74%	-3.46%	-3.48%
Net Working Capital to Revenue	-6.81%	-6.63%	-5.84%	-5.98%	-5.78%	-6.16%	-6.49%	-7.07%	-7.91%	-6.44%	-4.28%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($3.30)	($0.31)	($3.48)	$0.40	($6.85)	($0.08)	($0.21)	$0.14	$0.81	($4.31)	($0.46)
Adjusted Weighted Average Basic Shares Outstanding	864.10M	863.80M	863.10M	863.10M	862.50M	863M	863.20M	863.10M	862.60M	863.60M	864.40M
Adjusted Diluted Earnings per Share	($3.30)	($0.31)	($3.48)	$0.40	($6.85)	($0.08)	($0.21)	$0.14	$0.81	($4.31)	($0.47)
Adjusted Weighted Average Diluted Shares Outstanding	864.10M	863.80M	863.10M	864.30M	862.50M	863M	863.20M	863.80M	863.40M	863.60M	865.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	864.74M	864.15M	864.62M	863.28M	862.71M	862.38M	863.91M	863.26M	862.80M	862.50M	864.81M
Normalized Net Operating Profit after Tax (NOPAT)	-1,340	-172	-684	102	-561	-27	-316	-334	174	-4,306	-575
Normalized NOPAT Margin	-3.47%	-0.43%	-1.82%	0.28%	-1.52%	-0.07%	-0.89%	-0.94%	0.50%	-12.90%	-1.77%
Pre Tax Income Margin	-11.00%	-1.36%	-2.66%	0.69%	-35.39%	-0.98%	-1.06%	-1.08%	1.74%	-15.79%	-2.34%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-31.91	-3.41	-6.56	3.23	-94.03	-2.62	-1.41	-1.21	5.31	-46.90	-6.16
NOPAT to Interest Expense	-30.21	-1.41	-5.18	0.90	-66.81	-0.28	-2.02	-1.93	1.24	-39.14	-5.43
EBIT Less CapEx to Interest Expense	-28.92	-4.39	0.17	4.45	-89.28	-4.66	-0.04	-1.14	10.24	-33.65	-7.43
NOPAT Less CapEx to Interest Expense	-27.22	-2.39	1.55	2.13	-62.06	-2.32	-0.66	-1.86	6.17	-25.89	-6.70
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-11.54%	-6.73%	-8.16%	-11.60%	-12.90%	16,590.00%	-47.02%	-43.23%	-46.70%	-50.61%	40.81%
Augmented Payout Ratio	-12.02%	-6.95%	-8.60%	-12.15%	-15.59%	30,440.00%	-88.58%	-81.60%	-80.25%	-120.41%	97.27%

Frequently Asked Questions About Walgreens Boots Alliance's Financials

When does Walgreens Boots Alliance's financial year end?

According to the most recent income statement we have on file, Walgreens Boots Alliance's fiscal year ends in August. Their fiscal year 2024 ended on August 31, 2024.

How has Walgreens Boots Alliance's net income changed over the last 9 years?

Walgreens Boots Alliance's net income appears to be on a downward trend, with a most recent value of -$15.45 billion in 2024, falling from $4.28 billion in 2015. The previous period was -$3.53 billion in 2023. See Walgreens Boots Alliance's forecast for analyst expectations on what’s next for the company.

What is Walgreens Boots Alliance's operating income?

Walgreens Boots Alliance's total operating income in 2024 was -$14.08 billion, based on the following breakdown:

Total Gross Profit: $26.52 billion
Total Operating Expenses: $40.60 billion

How has Walgreens Boots Alliance revenue changed over the last 9 years?

Over the last 9 years, Walgreens Boots Alliance's total revenue changed from $103.44 billion in 2015 to $147.66 billion in 2024, a change of 42.7%.

How much debt does Walgreens Boots Alliance have?

Walgreens Boots Alliance's total liabilities were at $68.86 billion at the end of 2024, a 1.1% increase from 2023, and a 83.7% increase since 2015.

How much cash does Walgreens Boots Alliance have?

In the past 9 years, Walgreens Boots Alliance's cash and equivalents has ranged from $469 million in 2020 to $9.81 billion in 2016, and is currently $1.32 billion as of their latest financial filing in 2024.

How has Walgreens Boots Alliance's book value per share changed over the last 9 years?

Over the last 9 years, Walgreens Boots Alliance's book value per share changed from 28.25 in 2015 to 12.10 in 2024, a change of -57.2%.

Related Companies

This page (NASDAQ:WBA) was last updated on 5/20/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Walgreens Boots Alliance (WBA) Financials

Frequently Asked Questions About Walgreens Boots Alliance's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Walgreens Boots Alliance (WBA) Financials

Annual Income Statements for Walgreens Boots Alliance

Quarterly Income Statements for Walgreens Boots Alliance

Annual Cash Flow Statements for Walgreens Boots Alliance

Quarterly Cash Flow Statements for Walgreens Boots Alliance

Annual Balance Sheets for Walgreens Boots Alliance

Quarterly Balance Sheets for Walgreens Boots Alliance

Annual Metrics And Ratios for Walgreens Boots Alliance

Quarterly Metrics And Ratios for Walgreens Boots Alliance

Frequently Asked Questions About Walgreens Boots Alliance's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools